U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06909799) titled 'A Confirmatory Trial of Adjunctive NAC to Prevent and/or Treat Post Tuberculosis Lung Disease' on Nov. 08, 2024.
Brief Summary: The goal of this clinical trial is to evaluate if N-acetylcysteine (NAC) works to prevent and/or treat post-tuberculosis lung disease (PTLD) in patients with severe pulmonary impairment. It also aims to assess the safety of NAC. The main questions the study aims to answer are:
Does NAC improve lung function (FEV1%) over 12 months in participants with post-TB lung disease? What medical issues or adverse events do participants experience while taking NAC? Researchers will compare different durations of NAC t...